In addition to its occurrence in individuals without an underlying disorder, APS is prevalent in patients with systemic lupus erythematosus (SLE), with as many as 34% of lupus patients having circulating aPL [2,3,5]. This evidence concerns the gene FASLG and systemic lupus erythematosus.